Table 2.
Structures and biological activity data of compounds 9–22.
| Drug | Structure | Class | IC50a (μM) |
|---|---|---|---|
| N3 (9) | ![]() |
Mpro inhibitor | – |
| Disulfiram (10) | ![]() |
Alcohol deterrent | 9.35 |
| Carmofur (11) | ![]() |
Antineoplastic agent | 1.82 |
| Shikonin (12) | ![]() |
Pyruvate kinase M2 inhibitor | 15.75 |
| Tideglusib (13) | ![]() |
Anti-inflammatory and neuroprotective agents | 1.55 |
| PX-12 (14) | ![]() |
Thioredoxin-1 inhibitor | 21.39 |
| TDZD-8 (15) | ![]() |
GSK-3β inhibitor | 2.15 |
| Boceprevir (16) | ![]() |
Hepatitis C virus NS3/4A protease inhibitor | 4.13 |
| GC-376 (17) | ![]() |
Mpro inhibitor | 0.03 |
| MG-132 (18) | ![]() |
Proteasome inhibitor | 3.90 |
| 19 | ![]() |
Calpain inhibitors II | 0.97 |
| 20 | ![]() |
Calpain inhibitors XII | 0.45 |
| YH-53 (21) | ![]() |
SARS-CoV-1 Mpro inhibitor |
– |
| Teicoplanin (22) | ![]() |
Glycopeptide antibiotic | 1.50 |
SARS-CoV-2 Mpro IC50.













